The University of Chicago Header Logo

James Howard Tonsgard

Concepts (271)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with James Howard Tonsgard's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that James Howard Tonsgard has written about over time.
Reye Syndrome, 8 publications between 1981 and 1991, average publication date June 1986. Dicarboxylic Acids, 7 publications between 1985 and 1991, average publication date June 1988. Fatty Acids, 5 publications between 1988 and 1998, average publication date October 1992. Child, 24 publications between 1981 and 2025, average publication date August 2007. Neurofibromin 1, 3 publications between 1997 and 2025, average publication date February 2013. Neurofibromatosis 1, 15 publications between 1997 and 2025, average publication date September 2013. Neurofibromatosis 2, 5 publications between 1993 and 2025, average publication date May 2014. Clinical Trials as Topic, 4 publications between 2009 and 2019, average publication date January 2015. Neurofibromatoses, 6 publications between 2000 and 2025, average publication date November 2016. Skin Neoplasms, 5 publications between 2000 and 2025, average publication date December 2016. Pain Measurement, 3 publications between 2013 and 2025, average publication date August 2018. Neurilemmoma, 5 publications between 2013 and 2025, average publication date June 2019. Mitogen-Activated Protein Kinase Kinases, 3 publications between 2013 and 2025, average publication date December 2019. Neurofibroma, Plexiform, 6 publications between 2013 and 2025, average publication date December 2020. Patient Reported Outcome Measures, 3 publications between 2016 and 2025, average publication date February 2021. Neuroma, Acoustic, 2 publications between 2019 and 2023, average publication date September 2021. Angiogenesis Inhibitors, 2 publications between 2019 and 2025, average publication date August 2022. Cognitive Dysfunction, 2 publications between 2019 and 2025, average publication date September 2022. Bevacizumab, 3 publications between 2019 and 2025, average publication date December 2022. Protein Kinase Inhibitors, 2 publications between 2021 and 2025, average publication date June 2023.

To see the data from this visualization as text, click here.
Tonsgard's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (271)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_